When and where
Wednesday 11 March 2026, 9.00-16.30
LUMC building 3,  Buruma lecture hall

Morning program 9.00-13.30

From Model to Therapy, hDMT/RARE-NL Preclinical Network
This meeting is specifically aimed at preclinical researchers who use in vitro and in vivo preclinical disease models to  develop therapy strategies for rare diseases. Regulators and other stakeholders in this area are also welcome to join.
Program and Registration
From Model to Therapy: RARE-NL/hDMT Preclinical Network - RARE-NL

Afternoon program 13.30-16.30

RARE-NL @LUMC – Antisense oligonucleotides for n-of-few: on the way to the clinic

This RARE-NL meeting focuses on the development and implementation of antisense oligonucleotides for n-of-few  and n-of-1 indications. The meeting brings together researchers, clinicians and experts in access pathways to explore  how ASOs can be translated into clinical practice. The emphasis is on shared challenges and solutions that require  collaboration beyond individual UMCs.
Program and Registration
RARE-NL @LUMC - Antisense oligonucleotides for n-of-few: on the way to the clinic - RARE-NL